Jw Life Science Corp (234080) — Capital Reinvestment Ratio
Jw Life Science Corp (234080) has a Capital Reinvestment Ratio of 0.84x as of December 2025, meaning it reinvests 1% of its operating cash flow (₩5.08 Billion) in capital expenditures (₩4.27 Billion). See Jw Life Science Corp (234080) balance sheet quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Jw Life Science Corp Capital Reinvestment Ratio (2015–2025)
This chart tracks Jw Life Science Corp's Capital Reinvestment Ratio across 11 annual periods. Check Jw Life Science Corp investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Jw Life Science Corp (2015–2025)
Year-by-year Capital Reinvestment Ratio for Jw Life Science Corp from 2015 to 2025. For live market cap and broader valuation context, see Jw Life Science Corp market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.33x | ₩40.54 Billion | ₩13.43 Billion | ▲ +63.0% |
| 2024 | 0.20x | ₩50.69 Billion | ₩10.31 Billion | ▼ -7.6% |
| 2023 | 0.22x | ₩37.57 Billion | ₩8.27 Billion | ▼ -62.5% |
| 2022 | 0.59x | ₩14.13 Billion | ₩8.29 Billion | ▼ -6.7% |
| 2021 | 0.63x | ₩30.17 Billion | ₩18.98 Billion | ▲ +84.6% |
| 2020 | 0.34x | ₩46.75 Billion | ₩15.93 Billion | ▲ +2.2% |
| 2019 | 0.33x | ₩24.28 Billion | ₩8.09 Billion | ▲ +19.9% |
| 2018 | 0.28x | ₩36.13 Billion | ₩10.04 Billion | ▼ -30.1% |
| 2017 | 0.40x | ₩22.05 Billion | ₩8.77 Billion | ▼ -52.2% |
| 2016 | 0.83x | ₩16.08 Billion | ₩13.37 Billion | ▼ -7.0% |
| 2015 | 0.89x | ₩25.90 Billion | ₩23.14 Billion | — |